|
⚲
|
| Keyboard |
| Novartis Institutes for BioMedical Research Inc
✚
|
|
|---|---|
| CIK # | 0001673852 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001673852] | |
| 4 | [0001673852] | |
| 5 | [0001673852] | |
| SC 13D | [0001673852] | |
| SC 13G | [0001673852] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Novartis AG | |
| Novartis Institutes for BioMedical Research Inc | |
| Intellia Therapeutics Inc | |
| Surface Oncology Inc | |
| Q32 Bio Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Intellia Therapeutics Inc NTLA
Common Stock
|
2018-07-16 | Other | 25,074 | $0.00 | |
|
Intellia Therapeutics Inc NTLA
Common Stock
|
2018-06-18 | Other | 25,074 | $0.00 | |
|
Intellia Therapeutics Inc NTLA
Common Stock
|
2018-05-16 | Other | 25,074 | $0.00 | |
|
Surface Oncology Inc SURF
Common Stock
|
2018-04-23 | Buy | 766,666 | $15.00 | 11,499,990 |
|
Surface Oncology Inc SURF
Common Stock
|
2018-04-23 | Conversion | 909,090 | ||
|
Surface Oncology Inc SURF
Common Stock
|
2018-04-23 | Conversion | 2,272,726 | ||
|
Surface Oncology Inc SURF
Series A-1 Preferred Stock · derivative
|
2018-04-23 | Conversion | 5,214,286 | $0.00 | |
|
Surface Oncology Inc SURF
Series A Preferred Stock · derivative
|
2018-04-23 | Conversion | 1,571,429 | $0.00 | |
|
Q32 Bio Inc FIXX
Common Stock
|
2018-04-02 | Conversion | 1,979,226 | $0.00 | |
|
Q32 Bio Inc FIXX
Series B Preferred Stock · derivative
|
2018-04-02 | Conversion | 1,979,226 | $0.00 | |
|
Intellia Therapeutics Inc NTLA
Common Stock
|
2017-12-12 | Sell | 1,523,000 | $18.30 | 27,870,900 |
|
Intellia Therapeutics Inc NTLA
Common Stock
|
2017-03-03 | Other | 79,245 | $0.00 | |
|
Intellia Therapeutics Inc NTLA
Common Stock
|
2016-05-11 | Buy | 277,777 | $18.00 | 4,999,986 |
|
Intellia Therapeutics Inc NTLA
Common Stock
|
2016-05-11 | Conversion | 492,640 | ||
|
Intellia Therapeutics Inc NTLA
Common Stock
|
2016-05-11 | Conversion | 1,724,240 | ||
|
Intellia Therapeutics Inc NTLA
Series A-2 Preferred Stock · derivative
|
2016-05-11 | Conversion | 2,666,666 | $0.00 | |
|
Intellia Therapeutics Inc NTLA
Series B Preferred Stock · derivative
|
2016-05-11 | Conversion | 761,905 | $0.00 | |
|
Intellia Therapeutics Inc NTLA
Series A-1 Preferred Stock · derivative
|
2016-05-11 | Conversion | 4,761,905 | $0.00 | |
|
Intellia Therapeutics Inc NTLA
Common Stock
|
2016-05-11 | Conversion | 3,079,001 |